Combination therapy to prevent cardiovascular disease: slow progress

JAMA. 2013 Apr 17;309(15):1595-6. doi: 10.1001/jama.2013.3180.
No abstract available

MeSH terms

  • Antihypertensive Agents / administration & dosage*
  • Aspirin / administration & dosage*
  • Cardiovascular Diseases / diagnosis
  • Cardiovascular Diseases / prevention & control*
  • Cost Control
  • Drug Combinations*
  • Drug Costs
  • Drug Industry
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage*
  • Mass Screening
  • Medication Adherence
  • Platelet Aggregation Inhibitors
  • Practice Patterns, Physicians'
  • Primary Prevention
  • Secondary Prevention
  • Treatment Outcome

Substances

  • Antihypertensive Agents
  • Drug Combinations
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Platelet Aggregation Inhibitors
  • Aspirin